Expert Mounjaro vs Wegovy Comparison for UK Patients
Which Is Best Mounjaro or Wegovy: Key Mechanism Differences
Understanding which is best Mounjaro or Wegovy starts with their distinct mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone to reduce appetite and promote satiety after smaller meals. Mounjaro (tirzepatide) takes a dual approach, targeting both GIP and GLP-1 receptors simultaneously, which may provide additional metabolic benefits beyond appetite suppression. Both are prescription-only medicines that require clinical assessment to determine suitability.
When considering which is best Mounjaro or Wegovy for your circumstances, dosing schedules differ significantly. Wegovy follows a structured 16-week dose escalation from 0.25mg to the 2.4mg maintenance dose, with each step designed to minimise gastrointestinal side effects. Mounjaro uses a similar escalation approach but reaches a maximum maintenance dose of 15mg. Your prescriber will evaluate your medical history, current medications, and weight management goals to recommend the most appropriate option.
Wegovy vs Mounjaro Pricing: Complete UK Cost Comparison
Determining which is best Mounjaro or Wegovy often involves practical considerations like cost and availability. Wegovy pricing at EverydayMeds starts with the 0.25mg starter dose at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the 2.4mg maintenance dose (£209.99). New customers receive discount code FIRST40 at checkout, whilst returning customers use DOSE25, with these prices representing the final amount you'll pay. Our bundle options include the Intro Duo (0.25mg & 0.5mg) for £169.99 and the Ultimate Stability Trio providing three months of 2.4mg maintenance supply for £649.99.
Both Wegovy and Mounjaro are available through EverydayMeds, allowing direct price comparison during your clinical assessment. Bundle pricing provides convenience rather than savings, ensuring consistent supply without multiple orders. The Progress Trio (0.5mg, 1mg & 1.7mg) costs £369.99, whilst individual dose flexibility lets you adjust treatment based on tolerance and response. Your prescriber can discuss cost-effectiveness alongside clinical suitability when determining which is best Mounjaro or Wegovy for your situation.
Clinical Evidence: Which Is Best Mounjaro or Wegovy Studies
Clinical trials provide crucial insight when evaluating which is best Mounjaro or Wegovy for weight management. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved an average of approximately clinically studied weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 trial demonstrated sustained weight loss of approximately 15.2% at two years, whilst the SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events.
Mounjaro's SURMOUNT trial programme showed different results, but direct comparison isn't appropriate due to varying trial designs, participant populations, and endpoints. Both treatments demonstrate clinically meaningful weight loss when used alongside lifestyle modifications. Your prescriber will review the evidence relevant to your health profile rather than making broad comparisons about which is best Mounjaro or Wegovy universally.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy's effectiveness stems from its action as a GLP-1 receptor agonist, mimicking glucagon-like peptide-1, a hormone naturally released by your intestines after eating. This hormone signals satiety to your brain, reducing appetite and promoting the feeling of fullness after smaller meals. Additionally, Wegovy may reduce food cravings by acting on appetite centres in the brain, potentially making it easier to stick to a reduced-calorie diet. The once-weekly injection via FlexTouch pen provides consistent hormone levels, avoiding the peaks and troughs associated with shorter-acting medications. This sustained action supports long-term weight management when combined with increased physical activity and dietary changes.
Simple Online Ordering Process for UK Patients
Purchasing either treatment through EverydayMeds follows a streamlined three-step process designed for convenience and clinical safety. First, complete our 3-minute online clinical assessment covering your medical history, current medications, weight management goals, and previous treatment experiences. Next, our specialist prescribers review your assessment within 3 working days (or 24 hours with express service), evaluating whether Wegovy, Mounjaro, or alternative treatments best suit your needs. Finally, once approved, your medication arrives via next-day delivery in temperature-controlled packaging, ensuring the cold-chain is maintained from our GPhC-registered pharmacy (#9012878) to your door. All consultations include ongoing prescriber support and guidance on injection technique, dose escalation, and managing potential side effects.
Storage and Practical Considerations
Storage requirements often influence decisions about which is best Mounjaro or Wegovy for individual lifestyles. Wegovy offers superior travel flexibility, maintaining stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Before first use, both require refrigerated storage between 2-8°C. The FlexTouch pen system used by Wegovy provides user-friendly injection with automatic needle insertion and dose confirmation. Dose escalation is mandatory for both treatments, preventing patients from jumping directly to maintenance doses and reducing gastrointestinal side effects. Pre-filled pens eliminate dosing errors and provide accurate delivery of the prescribed amount.
Which Is Best Mounjaro or Wegovy: Individual Factors
Determining which is best Mounjaro or Wegovy requires personalised clinical evaluation rather than universal recommendations. Factors influencing treatment selection include your diabetes status, cardiovascular risk profile, previous weight management attempts, and tolerance to gastrointestinal side effects. Patients with type 2 diabetes might benefit from different considerations compared to those without diabetes, as both medications can affect blood glucose levels. Your prescriber will assess contraindications, drug interactions, and individual risk factors.
Lifestyle considerations also impact which is best Mounjaro or Wegovy for your circumstances. Travel frequency might favour Wegovy's extended room temperature stability, whilst dose scheduling preferences could influence choice. Both treatments require commitment to long-term use, as the STEP 1 extension study showed patients regained approximately two-thirds of weight lost within one year of stopping treatment. Weight management represents a long-term commitment rather than a short-term intervention.
Start Your Assessment Today
Both Wegovy and Mounjaro are available from EverydayMeds, with your prescriber helping determine which treatment aligns with your health profile and goals. Our clinical assessment considers your complete medical picture rather than applying generic recommendations about which is best Mounjaro or Wegovy. New customers can use code FIRST40 at checkout, whilst returning customers apply DOSE25 to access competitive pricing. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment, with specialist prescriber review and next-day delivery available across the UK. Take the first step towards clinically supervised weight management with expert guidance from our qualified healthcare professionals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
